The Hong Kong stock market finished session higher on Tuesday, 24 November 2020, as progress in developing an inexpensive coronavirus vaccine boosted hopes of a swift recovery, while a formal transition approval for US President-elect Joe Biden also lifted sentiment.
At closing bell, the benchmark Hang Seng Index added 0.13%, or 34.66 points, to 26,486.20, the highest since 5 March 2020. The Hang Seng China Enterprises Index grew 1.07%, or 113.18 points, to 10,666.53.
Vaccine excitement continues to support global markets. Overnight, British company Astrazeneca with partner Oxford University became the third vaccine maker this month to show better than expected efficacy in trials. The company showed its vaccine had up to 90% efficacy in protecting against COVID.
While this isn't as effective as peers Pfizer/BioNTech and Moderna, the vaccine is cheaper to make, easier to transport and intends to be sold at cost during the pandemic. Both Pfizer and Moderna intend to sell their vaccines at profit.
Stocks also got a boost after US President-elect Joe Biden received approval to begin the transition to the White House and after a report that he would pick former Federal Reserve Chair Janet Yellen to be the next Treasury secretary.
Alibaba Group Holding gained 2.3% to HK$270 on reports that more Hong Kong-listed companies will be added to the Stock Connect, a cross-border investment channel linking the city and the mainland. JD.com, which rivals Alibaba in e-commerce, added 1% to HK$348.20. Gaming company NetEase advanced 1.6% to HK$150.80.
Hong Kong Exchanges and Clearing, the local bourse operator, rallied 4% to HK$392 on expectations that it will benefit from increased trading volumes.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU